Skip to main content

Table 4 Factors associated with the anti-S1 IgG titre at the end of the study

From: Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France

Variable

DF

Parameter estimate

Standard error

t Value

Pr > |t|

Intercept

1

1.41916

1.71706

0.83

0.41

A history of COVID-19

1

7.84042

2.14416

3.66

0.0004

At least two doses of vaccine

1

7.42861

1.75461

4.23

<.0001

Being on the French national waiting list for kidney transplantation

1

3.77334

1.38702

2.72

0.0074

  1. The multivariate analysis covered all patients, regardless of their COVID-19 status. N = 135 patients, p < 0.0001 in a linear mixed model; R2 adjusted = 0.19. DF: degrees of freedom. Antibody titres were square-root-transformed